Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCRTR1 | O43613 | 2/20 | 0.41 |
| ▸ | HCRTR2 | O43614 | 2/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | CA12 | O43570 | 3/20 | 0.40 |
| ▸ | CA9 | Q16790 | 3/20 | 0.40 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.40 |
| ▸ | HTR1A | P08908 | 1/20 | 0.39 |
| ▸ | DRD2 | P14416 | 1/20 | 0.39 |
| ▸ | HTR2A | P28223 | 1/20 | 0.39 |
| ▸ | HTR7 | P34969 | 1/20 | 0.39 |
| ▸ | HTR6 | P50406 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 4/20 | 0.38 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31658296 | 0.93 | CA12 (0.46) | HCRTR1HCRTR2GAACA12CA9 | |
| SCHEMBL31658284 | 0.86 | CA12 (0.46) | CA12CA9HTR1ADRD2HTR2A | |
| SCHEMBL31658310 | 0.86 | HCRTR1 (0.39) | HCRTR1HCRTR2GAACA12CA9 | |
| SCHEMBL31658275 | 0.83 | GAA (0.49) | HCRTR1HCRTR2GAACA12CA9 | |
| SCHEMBL31658294 | 0.83 | GAA (0.49) | HCRTR1HCRTR2GAACA12CA9 | |
| SCHEMBL31658257 | 0.82 | GAA (0.42) | GAAHTR1ADRD2HTR2AHTR7 | |
| SCHEMBL31662439 | 0.81 | CA12 (0.46) | HCRTR1HCRTR2GAACA12CA9 | |
| SCHEMBL31658268 | 0.80 | CHRM5 (0.45) | HCRTR1HCRTR2GAARAB9ARXFP1 | |
| SCHEMBL31658297 | 0.76 | CYP1A2 (0.44) | GAACA12CA9HTR1ADRD2 | |
| SCHEMBL31658253 | 0.76 | GAA (0.46) | HCRTR1HCRTR2GAACA12CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025149586-A1 | HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF FATTY LIVER DISEASE | SCANDIEDGE THERAPEUTICS AB (SE) | 2025-07-17 | — | — | WO | disclosed |